Digitalising and mobilising new patient pathways
Research tools and in vitro diagnostics (IVD) sit at the core of modern healthcare innovation, spanning the journey from early scientific discovery through to clinical decision-making. Research tools support the analysis of biospecimens across academic, biopharma and pharmaceutical environments – generating the insights that drive drug discovery and development. As technologies progress through translational pathways, they evolve into IVD solutions that diagnose disease, guide treatment decisions and increasingly help predict patient outcomes.
Across both areas, data is redefining what’s possible. Advances in analytics, automation and digital platforms are accelerating the generation and interpretation of complex biological data, reshaping how disease is understood and treated.
At Hunter Healthcare, we support organisations operating across this rapidly evolving ecosystem through a specialist, partnership-led approach to talent and advisory services. Our global network connects clients with the expertise needed to scale innovation, strengthen capability and deliver impact across the full product lifecycle.
I have always been impressed with Hunter’s ability to deliver under any circumstance, no matter how challenging the recruitment is. Hunter have a diligent and process-orientated approach, which is underpinned by deep-rooted market networks and candidate relationships, across local, regional and national level. Hunter go above and beyond to really get under the skin of an organisation, ensuring they invest significant time up front on stakeholder engagement and cultural diagnosis. Hunter are responsive, stick to deadlines, have excellent market knowledge and write detailed but user-friendly reports and briefing documents.
Maria Kane
Chief Executive | North Middlesex University Hospital NHS Trust
